1-4 of 4
Giorgio Massimini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL –negative chronic myeloproliferative disorders

Clinical Trials & Observations Brief Report
Marianna David, Nicholas C. P. Cross, Sonja Burgstaller, Andrew Chase, Claire Curtis, Raymond Dang, Martine Gardembas, John M. Goldman, Francis Grand, George Hughes, Francoise Huguet, Louise Lavender, Grant A. McArthur, Francois X. Mahon, Giorgio Massimini, Junia Melo, Philippe Rousselot, Robin J. Russell-Jones, John F. Seymour, Graeme Smith, Alastair Stark, Katherine Waghorn, Zariana Nikolova, Jane F. Apperley
Journal: Blood
Blood (2006) 109 (1): 61–64.
https://doi.org/10.1182/blood-2006-05-024828
Published: 2006
Journal Articles

Survival advantage from imatinib compared with the combination interferon-α plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials

Clinical Trials & Observations
Lydia Roy, Joëlle Guilhot, Tillmann Krahnke, Agnès Guerci-Bresler, Brian J. Druker, Richard A. Larson, Steve O'Brien, Charlene So, Giorgio Massimini, François Guilhot
Journal: Blood
Blood (2006) 108 (5): 1478–1484.
https://doi.org/10.1182/blood-2006-02-001495
Published: 2006
Journal Articles

Retrospective Comparison of Imatinib Versus Interferon Plus Cytarabine (IFN/Ara-c) for Chronic Myelogenous Leukemia (CML) Patients in Chronic Phase (CP).

Francois Guilhot, MD, Lydia Roy, MD, Joelle Guilhot, BS, Tillmann Krahnke, BSR, Agnes Guerci, MD, Brian Druker, MD, Richard Larson, MD, Steve O’Brien, MD, Charlene So, PharmD, Giorgio Massimini, MD
Journal: Blood
Blood (2005) 106 (11): 165.
https://doi.org/10.1182/blood.V106.11.165.165
Published: 2005
Journal Articles

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

Clinical Trials & Observations
Walter Fiedler, Hubert Serve, Hartmut Döhner, Michael Schwittay, Oliver G. Ottmann, Anne-Marie O'Farrell, Carlo L. Bello, Randy Allred, William C. Manning, Julie M. Cherrington, Sharianne G. Louie, Weiru Hong, Nicoletta M. Brega, Giorgio Massimini, Paul Scigalla, Wolfgang E. Berdel, Dieter K. Hossfeld
Journal: Blood
Blood (2005) 105 (3): 986–993.
https://doi.org/10.1182/blood-2004-05-1846
Published: 2005